|
Status |
Public on Jan 12, 2018 |
Title |
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
29192207 |
|
Submission date |
Jun 15, 2017 |
Last update date |
Jul 25, 2021 |
Contact name |
Eugene Schuster |
E-mail(s) |
[email protected]
|
Phone |
+442088082619
|
Organization name |
Institute of Cancer Research
|
Department |
Breast Cancer Research
|
Lab |
Endocrinology
|
Street address |
123 Old Brompton Road
|
City |
London |
ZIP/Postal code |
SW7 3RP |
Country |
United Kingdom |
|
|
Platforms (2) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (27)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE100074 |
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [ChIP-Seq] |
GSE100075 |
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
|
Relations |
BioProject |
PRJNA390631 |